Literature DB >> 18959834

Renal protective effect of renin inhibition.

Theodore A Kotchen.   

Abstract

Entities:  

Year:  2008        PMID： 18959834     DOI： 10.1007/s11906-008-0088-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  7 in total

1.  Is there a pharmacologic basis for combination renin axis blockade?

Authors:  Norman K Hollenberg
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

2.  Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.

Authors:  Suzanne Oparil; Steven A Yarows; Samir Patel; Hui Fang; Jack Zhang; Andrew Satlin
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

3.  Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.

Authors:  Alan H Gradman; Roland E Schmieder; Robert L Lins; Juerg Nussberger; Yanntong Chiang; Martin P Bedigian
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

4.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Authors:  C E Mogensen; S Neldam; I Tikkanen; S Oren; R Viskoper; R W Watts; M E Cooper
Journal:  BMJ       Date:  2000-12-09

Review 5.  Renin inhibition in hypertension.

Authors:  Alan H Gradman; Rishi Kad
Journal:  J Am Coll Cardiol       Date:  2008-02-05       Impact factor: 24.094

6.  Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.

Authors:  David L Feldman; Liang Jin; Hong Xuan; Aurelie Contrepas; Yinong Zhou; Randy L Webb; Dominik N Mueller; Sandra Feldt; Frederick Cumin; Wieslawa Maniara; Elke Persohn; Helmut Schuetz; A H Jan Danser; Genevieve Nguyen
Journal:  Hypertension       Date:  2008-05-19       Impact factor: 10.190

Review 7.  Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.

Authors:  Moiz M Shafiq; Dileep V Menon; Ronald G Victor
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.